Factors Affecting Treatment in Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Ngo, P. [1 ]
Pinkston, C. [2 ]
Pham, D. [3 ]
Kloecker, G. [1 ]
机构：
[1] Univ Louisville, James Graham Brown Canc Ctr, Med Oncol, Louisville, KY 40292 USA
[2] Univ Louisville, Biostat, Louisville, KY 40292 USA
[3] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
NSCLC; untreated;
D O I：
10.1016/j.jtho.2018.08.955
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.15-23
引用
收藏
页码：S621 / S621
页数：1
相关论文
共 50 条
  • [41] The clinical prognostic factors of 889 patients with non-small cell lung cancer
    Han, Yiping
    CANCER RESEARCH, 2016, 76
  • [42] The risk factors for brain metastases in patients with non-small cell lung cancer
    Lim, Jun Hyeok
    Um, Sang-Won
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [43] Prognostic factors in elderly patients with unresectable non-small cell lung cancer
    Kimura, T
    Kudoh, S
    Hirata, K
    Takifuji, N
    Negoro, S
    Yoshikawa, J
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1379 - 1383
  • [44] Clinicopathological Factors in Non-Small Cell Lung Cancer Patients with Bone Metastases
    Ulas, Arife
    Bilici, Ahmet
    Durnali, Ayse
    Tokluoglu, Saadet
    Akinci, Sema
    Silay, Kamile
    Oksuzoglu, Berna
    Alkis, Necati
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S535 - S535
  • [45] Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Honorio, M.
    Guerra Pereira, N.
    Tereso, A.
    Almeida, M. A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S881 - S881
  • [46] Histopathological Risk Factors Correlation in Patients with Non-Small Cell Lung Cancer
    Pritami, A. A.
    Infianto, A.
    Soemarwoto, R. A. S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S416 - S416
  • [47] On the pharmacogenetics of non-small cell lung cancer treatment
    Santarpia, Mariacarmela
    Rolfo, Christian
    Peters, G. J.
    Leon, Leticia G.
    Giovannetti, Elisa
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (03) : 307 - 317
  • [48] Pembrolizumab for the treatment of non-small cell lung cancer
    Muller, Mirte
    Schouten, Robert D.
    De Gooijer, Cornedine J.
    Baas, Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 399 - 409
  • [49] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [50] The treatment of advanced non-small cell lung cancer
    Spiro, SG
    Silvestri, GA
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 287 - 291
12345